The Eye & Ear Foundation’s July 11th webinar, “Next-Generation Therapies to Slow or Halt AMD Vision Loss,” featured presentations by Dr. Jay Chhablani, MD, and Dr. John Ash, PhD. “We […]
Read More… from Next-Generation Therapies to Slow or Halt AMD Vision Loss
The Eye & Ear Foundation closed out April with a webinar entitled, “Age-Related Macular Degeneration and Geographic Atrophy: Advancements in Research and Care.” The first presenter was Kunal Dansingani, MBBS, […]
The Department of Ophthalmology at the University of Pittsburgh School of Medicine was the first in the world to use optogenetics to restore vision. The Eye & Ear Foundation’s August […]
When thinking of eye diseases, most people will immediately think of things such as macular degeneration, glaucoma, and diabetic retinopathy. However, many other viral diseases of the eye affect millions […]
Astellas Pharma Inc. and University of Pittsburgh have entered into a research collaboration agreement focused on the discovery and optimization of clinical candidates for the treatment of dry age-related macular […]
Exciting breakthroughs in ocular drug delivery and release may provide relief for vision patients who rely on eye drops, thanks to the work of Morgan Fedorchak, PhD, Assistant Professor of […]
Scientists in the Department of Ophthalmology at the University of Pittsburgh School of Medicine continue to advance their research on a variety of areas that could eventually help solve the […]
The University of Pittsburgh Medical Center has implanted the first patient in the United States with a new wireless retinal device as part of a clinical trial aimed at restoring […]
Read More… from First in the U.S. to Implant Wireless Retinal Device
Age-Related Macular Degeneration (AMD) is the leading cause of irreversible vision loss in the United States, affecting nearly two million people, according to the American Academy of Ophthalmology. With the […]
Read More… from Turning Back the Clock on Macular Degeneration